Cargando…

Perceptions of US Adolescents and Adults With Sickle Cell Disease on Their Quality of Care

IMPORTANCE: Sickle cell disease (SCD) is the most common inherited red blood cell disorder in the United States, and previous studies have shown that individuals with SCD are affected by multiple health disparities, including stigmatization, inequities in funding, and worse health outcomes, which ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanter, Julie, Gibson, Robert, Lawrence, Raymona H., Smeltzer, Matthew P., Pugh, Norma L., Glassberg, Jeffrey, Masese, Rita V., King, Allison A., Calhoun, Cecelia, Hankins, Jane S., Treadwell, Marsha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260622/ https://www.ncbi.nlm.nih.gov/pubmed/32469413 http://dx.doi.org/10.1001/jamanetworkopen.2020.6016

Ejemplares similares

Examining Mental Health, Education, Employment, and Pain in Sickle Cell Disease
por: Harris, Kelly M., et al.
Publicado: (2023)

Sex-based differences in the manifestations and complications of sickle cell disease: Report from the Sickle Cell Disease Implementation Consortium
por: Masese, Rita V., et al.
Publicado: (2021)

Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA
por: Smeltzer, Matthew P, et al.
Publicado: (2021)

Burden of Aging: Health Outcomes Among Adolescents and Young Adults With Sickle Cell Disease
por: Howell, Kristen E., et al.
Publicado: (2023)

“The project did not come to us with a solution”: Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease
por: Baumann, Ana A., et al.
Publicado: (2023)

Perspectives of individuals with sickle cell disease on barriers to care
por: Phillips, Shannon, et al.
Publicado: (2022)

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study
por: Hankins, Jane S, et al.
Publicado: (2020)

Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study
por: Cronin, Robert M., et al.
Publicado: (2019)

Blood Transfusion: Knowledge, Perspectives, and Experience of Individuals With Sickle Cell Disease
por: Lawrence, Raymona H, et al.
Publicado: (2020)

An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model
por: Treadwell, Marsha J., et al.
Publicado: (2022)

Barriers to Pediatric Sickle Cell Disease Guideline Recommendations
por: Cabana, Michael D., et al.
Publicado: (2019)

Publication of data collection forms from NHLBI funded sickle cell disease implementation consortium (SCDIC) registry
por: Glassberg, Jeffrey A., et al.
Publicado: (2020)

Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program
por: Nottage, Kerri A., et al.
Publicado: (2013)

From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia
por: Hankins, Jane S., et al.
Publicado: (2014)

What does it mean to be affiliated with care?: Delphi consensus on the definition of “unaffiliation” and “specialist” in sickle cell disease
por: Lamont, Andrea E., et al.
Publicado: (2022)

Is sickle cell disease the same everywhere?
por: Hankins, Jane
Publicado: (2012)

Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS® to ASCQ-Me℠
por: Keller, San, et al.
Publicado: (2017)

Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance
por: Mathias, Joacy G., et al.
Publicado: (2021)

Inclusion of the US Preventive Services Task Force Recommendation for Mammography in State Comprehensive Cancer Control Plans in the US
por: Soori, Mehrnoosh, et al.
Publicado: (2022)

Imputation-Based Genomic Coverage Assessments of Current Human Genotyping Arrays
por: Nelson, Sarah C., et al.
Publicado: (2013)

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
por: Kanter, Genevieve P., et al.
Publicado: (2019)

Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings
por: Strunk, Crawford, et al.
Publicado: (2020)

Assent, parental consent and reconsent for health research in Africa: thematic analysis of national guidelines and lessons from the SickleInAfrica registry
por: Munung, Nchangwi Syntia, et al.
Publicado: (2022)

Public Perceptions of Physician Attire and Professionalism in the US
por: Xun, Helen, et al.
Publicado: (2021)

Academic Performance of Children With Sickle Cell Disease in the United States: A Meta-Analysis
por: Heitzer, Andrew M., et al.
Publicado: (2021)

Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks
por: Keller, San D, et al.
Publicado: (2014)

Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative
por: Treadwell, Marsha J., et al.
Publicado: (2022)

Mast Cell Activation Syndrome as a Significant Comorbidity in Sickle Cell Disease
por: Afrin, Lawrence B.
Publicado: (2014)

Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients
por: Wonkam, Ambroise, et al.
Publicado: (2015)

Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: The emergency department providers’ perspective
por: Masese, Rita Vanessa, et al.
Publicado: (2019)

CureSCi Metadata Catalog–Making sickle cell studies findable
por: Pan, Huaqin, et al.
Publicado: (2022)

Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach
por: Alberts, Nicole M, et al.
Publicado: (2020)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Evidence for Weak Selective Constraint on Human Gene Expression
por: Glassberg, Emily C., et al.
Publicado: (2019)

Common data model for sickle cell disease surveillance: considerations and implications
por: Smeltzer, Matthew P, et al.
Publicado: (2023)

Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease
por: Lubeck, Deborah, et al.
Publicado: (2019)

Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care
por: Evensen, Christian T., et al.
Publicado: (2016)

Patient Experience at US Hospitals Following the Caregiver Advise, Record, Enable (CARE) Act
por: Lee, Courtney R., et al.
Publicado: (2023)

Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease
por: Hankins, J. S, et al.
Publicado: (2023)

Inflammation, Hemolysis, and Erythropoiesis Lead to Competitive Regulation of Hepcidin and Possibly Systemic Iron Status in Sickle Cell Disease
por: Ginzburg, Yelena Z., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qpstbmll9pl6hm55j63tr089f3